Skip to content

A Study of an Oral Nutrition Supplement (ONS) in Children.

A Study of an Oral Nutrition Supplement (ONS) in Children.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02056275
Enrollment
256
Registered
2014-02-05
Start date
2013-08-31
Completion date
2014-04-30
Last updated
2015-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Growth

Brief summary

To assess the effect of oral nutritional supplementation with dietary counseling versus dietary counseling alone on growth of preschool children over a period of 90 days.

Interventions

OTHERNutrition supplement + dietary counseling

Nutritionally balanced nutritional supplement providing 1.0 kcal/ml.

OTHERDietary Counseling

Dietary counseling provided at each study visit by study dietitian.

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
24 Months to 72 Months
Healthy volunteers
No

Inclusion criteria

1. Age of 24-72 months (inclusive), both genders. 2. Diagnosed with current acute upper respiratory tract infection. 3. Weight-for-age between 3rd - 15th percentile according to WHO Growth Charts. 4. Identified as a picky eater. 5. Able to consume foods and beverages orally. 6. Willing to abstain from additional non-study provided protein supplements or nutritional supplements throughout the study period.

Exclusion criteria

1. Current illness requiring hospitalization. 2. Gastrointestinal infection and/or acute diarrhea at the time of inclusion in the study. 3. Currently taking medication that could affect absorption/metabolism of study product or weight of the child. 4. Diagnosed with recurrent respiratory infections due to cystic fibrosis, immunodeficiency syndromes, and congenital abnormalities of the respiratory tract, congenital lung and ciliary abnormalities, an unsuspected foreign body and asthma. 5. Active tuberculosis, acute hepatitis B or C, or HIV, malignancy. 6. History of diabetes mellitus. 7. Received antibiotic therapy within the last two weeks before start of the study. 8. Dysphagia, aspiration risk, difficulty in swallowing due to acquired / congenital abnormalities that would hamper oral intake of the study product. 9. Clinically significant nutritional deficiency requiring specific treatment with any other nutritional supplement (not study product).

Design outcomes

Primary

MeasureTime frameDescription
WeightStudy Day (SD) 1 to 90Change in weight-for-age from Day 1 to Day 90

Secondary

MeasureTime frameDescription
Respiratory InfectionsStudy Day (SD) 1 to 90Number and duration of recurrent acute upper respiratory tract infections per month during the study period.
Sick DaysStudy Day (SD) 1 to 90Number of sick days per month assessed by the presence of any acute upper respiratory tract infections during the study period.
Doctor VisitsStudy Day (SD) 1 to 90Number of unscheduled visits per month due to development of acute upper respiratory tract infections during the study period.
Dietary IntakeStudy Day (SD) 1 to 90Average energy consumption (values and changes from baseline).
Appetite ScoreStudy Day (SD) 3, 10, 30, 60 and 90Change in appetite score (values and changes from baseline)

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026